Drug Product CDMOs

SK bioscience

South Korea

SK bioscience is a South Korean vaccine-focused biopharmaceutical company that also operates as a CDMO. Listed on KOSPI (302440), they develop proprietary vaccines (influenza, varicella, COVID-19, pneumococcal, HPV, RSV) and provide CDMO/CMO services for vaccine manufacturing. They acquired a controlling stake in German CDMO IDT Biologika for approximately $244M, gaining manufacturing sites in Dessau (Germany) and Rockville (Maryland, USA). SK bioscience collaborates with the Bill & Melinda Gates Foundation, CEPI, and international vaccine initiatives. They have WHO prequalified products.

SMS Pharmaceuticals Ltd

India

SMS Pharmaceuticals Ltd. is a listed Indian pharmaceutical company and global player in API manufacturing, established in 1990. The company operates four multi-product manufacturing facilities and two research centers, employing over 1,000 people and exporting to 75+ countries. SMS has export house status and is expanding CDMO services with a planned Rs 250 crore expansion.

Sofgen Pharmaceuticals

United States

Sofgen Pharmaceuticals, part of Procaps Group, is an integrated softgel CDMO that offers end-to-end solutions in softgel technologies from development through delivery. The company serves pharmaceutical, OTC, and nutraceutical customers, with operations across 13 countries in the Americas and customers in 50+ countries.

SOFIE

United States

SOFIE (formerly SOFIE Biosciences) is a U.S.-based radiopharmaceutical company that develops, manufactures, and distributes PET imaging agents and theranostic radiopharmaceuticals. The company operates 14 network pharmacy sites and a Theranostics Center of Excellence in Totowa, NJ. SOFIE offers contract manufacturing services for radiopharmaceuticals under 21 CFR 211 and 212 cGMP standards.

SpectronRx

Belgium

SpectronRx is a radiopharmaceutical CDMO headquartered in Belgium with manufacturing facilities in Indiana, USA, and Danbury, Connecticut. The company specializes in end-to-end radiopharmaceutical and theranostic services including mAb, nanobody, and peptide radiolabeling with a wide range of isotopes (Ac-225, Pb-212, Lu-177, I-123/131, Cu-64/67, etc.), isotope production via cyclotron (16-70 MeV), worldwide cold-chain logistics, and regulatory consulting from IND filing through FDA approval. They operate 3 CDMO facilities with multiple cleanrooms and GMP-aligned space totaling approximately 200,000 sq-ft.

Standard Chem. & Pharm. Co. Ltd

Taiwan

Standard Chem. & Pharm. Co., Ltd. (SCP), established in 1967 in Taiwan, is a renowned global pharmaceutical manufacturer and CDMO with a strong international presence. Their investor materials and pharma alliance documents explicitly describe them as offering CMO/CDMO services. They have manufacturing plants in Tainan (Plant 1 and Plant 2) and operations in Vietnam, Philippines, Thailand, Samoa, China (Taizhou/Jiangsu and Shanghai). The company has collaborated with major Japanese pharmaceutical companies and offers drug development and innovative drug delivery systems. They are a publicly listed company on the Taiwan stock exchange (Stock Symbol: 1720).

Stira Pharmaceuticals (Sterile Injectable CDMO)

United States

Stira Pharmaceuticals is a U.S.-based CDMO specializing in the development and cGMP manufacture of complex sterile injectable products, with integrated analytical capabilities. Founded in 2019, the company serves the U.S. market with services spanning small molecules, peptides, oligonucleotides, and biosimilars in formats including vials, syringes, IV bags, and cartridges with batch sizes up to 2,000L.

Sumitomo Chemical Co., Ltd.

Japan

Sumitomo Chemical Co., Ltd. is a major Japanese chemical company whose Advanced Medical Solutions Sector provides CDMO services for small molecule APIs and intermediates, oligonucleotide production (including gRNA for genome editing), and regenerative medicine/cell therapies through its S-RACMO joint venture with Sumitomo Pharma. The company also operates large agrochemical, IT materials, and essential materials businesses.

Symbiosis Pharmaceutical Services

United Kingdom

Symbiosis Pharmaceutical Services is a world-class sterile fill-finish CDMO based in Stirling, UK, specializing in the GMP manufacture of liquid and lyophilized biological and small molecule drug products. The company serves clinical trial and commercial scale with FDA-inspected and MHRA-licensed facilities. Symbiosis has manufactured its first 10,000-vial commercial batch for a cancer immunotherapy currently in Phase III trials. The company handles a full range of biologics including ATMPs, viral vectors, mAbs, ADCs, RNA/peptide therapies, and vaccines.

Symeres

Netherlands

Symeres is a leading mid-sized transatlantic Contract Research, Development and Manufacturing Organization (CRDMO) providing integrated drug discovery and development services from idea to IND. With 600+ scientists across 9 global sites in Europe and North America, the company combines medicinal chemistry, ADME-tox, biology, formulation development, analytical services, and GMP manufacturing up to 1,000 L scale. The company recently acquired DGr Pharma and Exemplify BioPharma to expand its CMC capabilities.

Syngene International

India

Syngene International is a leading Indian Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated services spanning drug discovery through commercial manufacturing for both small and large molecules. The company has long-term research collaborations with Bristol Myers Squibb (extended until 2035) and Amgen. Syngene recently opened its first US manufacturing facility in Rockville, Maryland, and added a bioconjugation suite in Bengaluru for end-to-end ADC development. The company has 20 kL single-use drug substance capacity for biologics.

Sypharma Pty Ltd

Australia

Sypharma is an Australian specialty contract manufacturing group operating since 2005. They develop and manufacture therapeutic goods, veterinary products, and specialty consumer products. They specialize in contract manufacturing for early clinical through Phase III clinical trials and have multipurpose cleanrooms for oral, topical, and parenteral drug products. They manufacture both large and small volume parenterals and have a veterinary manufacturing suite. Licensed by FDA, TGA, and ISO 13485 certified. They partnered with Schott on sterile fill/finish capabilities.

SyVento BioTech

Poland

SyVento BioTech is a Polish biotechnology CDMO specializing in lipid-based nanocarrier formulations and LNP (lipid nanoparticle) technology for mRNA-based drug products. They offer comprehensive CDMO services for pharma and biotech innovators, covering mRNA synthesis and LNP encapsulation. The company opened a new mRNA manufacturing facility (FlexFactory by Cytiva) spanning over 7,000 m2 including lab and production areas. They have partnerships with Cytiva and signed a Letter of Intent with Mabion S.A. for biologics manufacturing collaboration.

Tanvex Biopharma USA, Inc

Taiwan

Tanvex BioPharma USA is a vertically-integrated biopharmaceutical company that has launched a CDMO division (Tanvex CDMO) offering pre-clinical through commercial-scale contract manufacturing of microbial and mammalian-derived biotherapeutics. Founded by Dr. Allen Chao (former founder/CEO of Watson Pharmaceuticals). They received FDA approval for Nypozi (biosimilar filgrastim) and have an FDA-accepted biosimilar BLA. The CDMO offers end-to-end biologics manufacturing services. Their San Diego facility is FDA-registered with 1 approved product (injectable). They have capabilities in both biosimilar development and contract manufacturing for third parties.

TAPI (Teva API)

Netherlands

TAPI (Teva Active Pharmaceutical Ingredients) is the API division of Teva Pharmaceutical Industries, positioned as the world's leading international supplier of APIs with 350+ products in their portfolio. They offer integrated API and CDMO services, leveraging 85+ years of API development and manufacturing expertise. TAPI provides customized solutions including complex API development, peptide manufacturing (including GLP-1 capability), and end-to-end manufacturing. They have a partnership with Antheia for biosynthetic pharmaceutical ingredients and with Sagimet Biosciences for resmetirom API. TAPI operates globally with multiple manufacturing sites.

ten23 health

Switzerland

Swiss CDMO specializing in formulation, analytical and process development, sterile manufacturing (fill and finish), and testing of injectable medicines. First CDMO in the pharmaceutical industry for injectables to be B Corp certified. Operates from Basel and Visp, Switzerland. Opened new VIVA2 facility with expanded sterile manufacturing lines. QC laboratories approved by both Swissmedic/RHI and FDA. Partners with BD on Libertas wearable injector commercialization. Supports biologics, small molecules, and RNA therapeutics.

Theon Pharmaceuticals Ltd.

India

Indian pharmaceutical contract manufacturer (third-party manufacturer) based in Baddi, Himachal Pradesh. WHO-GMP and ISO 9001:2008 certified. Specializes in manufacturing tablets, capsules, dry syrups, and injectables. Ranked among top 10 leading injectable companies. Launched new state-of-the-art injectable and ophthalmic formulations facility in October 2024 for regulated markets. Has multiple production sections: General, Beta Lactam, Cephalosporins, Dry Powder Injectable. Exports to Africa, South East Asia, CIS, Latin America, and Asia Pacific. Has 12 FDA-approved products including injectables and oral tablets.

Thépenier Pharma & Cosmetics

France

French CDMO and OEM-ODM with over 60 years of experience, specializing in development and manufacturing of pharmaceutical, skincare, personal care, and makeup products. Part of an international group with French-Japanese DNA (parent company is Japanese cosmetics manufacturer). All products manufactured in GMP-compliant environment. Pharmaceutical specialization in dermatological products and ENT (ear, nose, throat) sphere products. Revenue of 117M USD (40% export), 850 employees, 70 R&I researchers, 60 engineers/pharmacists. Facilities in Normandy (2 sites) and Orleans, France.

The Ritedose Corporation

United States

The largest US CDMO specializing in sterile Blow-Fill-Seal (BFS) technology for aseptic manufacturing of unit-dose medications. Based in Columbia, South Carolina with a 500,000+ sq ft facility and production capacity of over 2.6 billion units annually. Delivered more than 12 billion doses since 2012 with no patient interruptions. Provides both CDMO services and has a generics division. Offers the largest nebulized drug portfolio in the US. Key products include ophthalmic, respiratory, and inhalation medications. Has co-developed 80%+ of new BFS products over the past decade. 100% customer retention for 25 years. Recent investments include $17M cGMP lab expansion and seventh Syntegon packaging line. 16 FDA-approved products.

Thermo Fisher Scientific Inc.

China

One of the world's largest pharmaceutical CDMOs through its Patheon pharma services division. Provides end-to-end pharmaceutical development and manufacturing services for both small molecules and biologics, from API manufacturing through drug product, sterile fill/finish, packaging, and commercial supply. Operates 31+ FDA-registered facilities globally. 158 FDA inspections on record (52 NAI, 104 VAI, 2 OAI). Also provides cell therapy manufacturing solutions (CTS Rotea cell processing system), laboratory informatics, bioprocessing equipment, and reagents. 4 FDA-approved drug products. Revenue >$40B (full company).

Tiefenbacher Group

Cyprus

Purpose-driven, family-owned healthcare company pioneering healthcare since 1963, headquartered in Cyprus. Delivers best-in-class solutions across the entire pharmaceutical value chain from API distribution through development, manufacturing, and registration of affordable medicines. 900+ employees, 400+ customers, 180+ finished dosage form products, serving patients in 80+ countries. Production capacity up to 3 billion units per year. Manufacturing sites in Cyprus (large-scale oral solid dose, SPC waiver site) and Hyderabad, India (specialized high-potent manufacturing block for oncology, FDA-inspected). Includes Tiefenbacher Laboratories (TBD Pharmatech) as API CDMO division. Offers ICH stability studies, technology transfer, analytical laboratory services, and EU batch testing/release.

Tiofarma

Netherlands

Tiofarma is a Dutch CDMO specializing in complex semi-solid formulations (creams and ointments) and emergency nasal sprays, offering services from pre-formulation through commercial supply. The company operates an EU-GMP and FDA-licensed manufacturing facility in Oud-Beijerland, Netherlands, with in-house R&D and analytical laboratories.

T.Man Pharma Company Limited

Thailand

T.Man Pharma Company Limited is a Thai public company established in 1991, specializing in the production and distribution of modern drugs, herbal medicines, food supplements, cosmetics, and health products. With 500-999 employees, the company operates GMP PIC/s certified manufacturing facilities and serves both domestic and international markets. Listed as a CMO/CDMO on CPHI and registered with FDA Thailand.

Towa International

Spain

Towa International is the international hub of Japanese generics company Towa Pharmaceutical, headquartered in Barcelona, Spain. The company researches, develops, manufactures, and distributes generic and value-added medicines worldwide, with direct presence in the US (via Breckenridge Pharmaceutical), Europe (Spain, Italy, Portugal), and 40+ countries. Towa International also operates a CMO/CDMO line, offering production capabilities to partners. It recently added a new high-containment area for potent APIs.

Tulip Lab Pvt Ltd

India

Tulip Lab Pvt Ltd is an Indian pharmaceutical manufacturing company headquartered in Mumbai. ISO 22000 certified and PIC/S certified, they manufacture allopathic and herbal products including tablets, capsules, liquids, and topicals. Their product range covers essential care, lifestyle diseases, cardiology, women's well-being, and metabolic disorders. They offer formulation development, private label, and contract manufacturing services with GMP-compliant facilities.

UI Pharmaceuticals

United States

UI Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States, operated by the University of Iowa. They offer comprehensive drug product CDMO services from formulation development through commercialization. In 2023, they launched a new 16,000 sq ft sterile processing facility with fill lines. They serve pharmaceutical, biotech, pediatrics, oncology, and research organizations worldwide.

Ultratech India Limited

India

Ultratech India Limited is an integrated Indian pharmaceutical company established in 1992, manufacturing pharmaceutical finished dosage forms, Active Pharmaceutical Ingredients, and drug intermediates. They specialize in pulmonary drug delivery systems (DPI and pMDI inhalation products) and offer Custom Research and Manufacturing Services (CRAMS) including custom synthesis, process development, private labeling, and contract manufacturing. Extensive API portfolio covers cardiovascular, antifungal, antihistamine, anti-asthmatics, antiviral, erectile dysfunction, and other therapeutic segments. WHO GMP, ISO 9001, ISO 14001 certified.

UNI-PHARMA S.A.

Greece

UNI-PHARMA S.A. is a major Greek pharmaceutical company (part of the Tsetis Group) with over 60 years of operations. It researches, develops, produces, and distributes pharmaceutical products, food supplements, and medical devices. It holds the first place in sales (units) among purely Greek companies in the Greek pharmaceutical market. The company offers contract manufacturing services (listed as CMO/CDMO on PharmaSource) while also marketing its own extensive portfolio of generic medicines across multiple therapeutic categories. Their product range includes a very wide array of small-molecule generics.

Unison Pharmaceuticals Private Limited

India

Unison Pharmaceuticals Private Limited is an Indian pharmaceutical company established in 1981, recognized as a Contract Manufacturing Organisation (CMO) providing quality and affordable medicines. They handle testing, production, and full packaging. The company website has minimal content but search results confirm they are a CMO supplying pharmaceutical formulations including tablets.

Unolab Manufacturing

Spain

Unolab Manufacturing is a Spanish CDMO founded in 2008, specialized in development and manufacturing of sterile unit-dose liquid formulations using Blow-Fill-Seal (BFS Bottelpack) technology. Focused primarily on ophthalmic and respiratory products including saline solutions, hyaluronic acid formulations, and inhalation products. Operates an 18,000 m2 facility in Getafe, Spain with capacity exceeding 600 million doses per year. Products exported to 25+ countries. Also offers tech transfer, out-licensing, and product development services across the full product lifecycle.

Upperton Pharma Solutions

United Kingdom

Upperton Pharma Solutions is a UK-based CDMO with an award-winning 60,000 sq ft development and manufacturing facility (Trent Gateway) in Nottingham. They provide integrated services from pre-clinical through late-phase manufacture for oral solids, nasal, pulmonary, and parenteral dosage forms. They recently built a new 7 million GBP sterile fill/finish manufacturing facility with MHRA submission. Services include formulation development, clinical supply manufacturing (Phase I-III), process scale-up and optimization, quality control, and analytical development and validation.

URSATEC GmbH

Germany

URSATEC GmbH is a German company founded in 1993 specializing in preservative-free spray dosing systems and contract manufacturing. They are the inventor and market leader in dosing systems for preservative-free sprays using their patented 3K and COMFORT packaging technologies. They offer a 'ONE Source' concept covering product development, raw materials sourcing, dosage systems, sterilization, sterile filling, lab services, and regulatory affairs for pharmaceuticals, medical devices, food supplements, and cosmetics. They operate from Tholey, Germany with ISO 13485, ISO 9001, and ISO 15378 certifications. While they do offer contract filling services for sterile products through qualified partner companies, their primary identity is as a dosing system inventor and preservative-free product specialist.

VintaBio

United States

VintaBio is a US-based viral vector CDMO that recently emerged from stealth, specializing in simplified viral vector manufacturing for gene therapies. The company claims 60% reduction in process time, 30% reduction in raw material costs, 5x increase in high-purity vector production, and 90% full capsids through its proprietary VintaProcess technology. Team has 120+ years of combined cell and gene therapy experience. Recently opened a custom-built manufacturing facility in Philadelphia.

Viralgen

Spain

Viralgen is a premier CDMO specializing exclusively in AAV-based gene therapy manufacturing, founded in 2017 as a subsidiary of AskBio within the Bayer AG group. Claims the world's largest manufacturing capacity dedicated to AAV. Operates from a cGMP facility in San Sebastian, Spain with bioreactors up to 2,000L. Offers end-to-end services from early construct optimization to commercial campaigns. 50+ clients across US, Europe, Asia, and Australia. 10+ years of lentiviral/AAV experience. 200+ batches in bioreactor. 130+ employees. 7 dedicated cleanrooms. Proprietary TESSA technology platform (from AskBio).

ViroCell Biologics

United Kingdom

ViroCell Biologics is a UK-based CDMO specializing exclusively in the design, optimization, and GMP manufacturing of lentiviral and retroviral vectors for clinical trials. Described as the UK's first clinical trial-focused viral vector manufacturer. Operating from a facility at Great Ormond Street Hospital in London, the company focuses on innovation-driven viral vector design, de-risking, and delivery. The facility reportedly more than doubles Britain's viral vector manufacturing capacity.

Volcke Aerosol Italy S.r.l.

Italy

Volcke Aerosol is a family-owned contract manufacturer with 55 years of experience specializing in the development and filling of aerosols and sprays. The company operates three production sites in Europe (Belgium, Italy, UK) and provides full-service solutions from formulation development through filling, labeling, and packaging.

Waisman Biomanufacturing

United States

Waisman Biomanufacturing is an academic CDMO based at the Waisman Center at the University of Wisconsin-Madison, specializing in advancing novel biologics and vaccines into early clinical trials. The facility manufactures plasmid DNA, recombinant proteins, cell therapeutics, extracellular vesicle/secretome products, live biotherapeutic products, and viral vectors under cGMP conditions.

Woodstock Sterile Solutions

United States

Woodstock Sterile Solutions is a leading CDMO specializing in aseptic pharmaceutical manufacturing of sterile liquid formulations using advanced blow-fill-seal (BFS) technology. Based in Woodstock, Illinois, the company has a decades-long track record in clinical development through full-scale commercial production, with particular expertise in ophthalmic and respiratory products as well as complex solutions, suspensions, and emulsions.

Wooshin Labottacah Co., Ltd

South Korea

Wooshin Labottacah Co., Ltd is a South Korean manufacturer specializing in hydrogel patches, ODF (orally disintegrating film), and transdermal drug delivery products. The company provides OEM/ODM manufacturing services and has a European subsidiary with EU-GMP certification in Slovenia. Wooshin has FDA registration for manufacturing and holds an exclusive licensing agreement with Aspen Healthcare for Lidocaine medicated plasters.

WuXi Biologics

China

WuXi Biologics is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) for biologics, with over 12,000 employees across the US, Ireland, Germany, China, and Singapore. The company provides end-to-end solutions from discovery through commercial manufacturing for biologics including monoclonal antibodies, bispecifics, ADCs, vaccines, and mRNA products using both mammalian and microbial expression systems.

Xellia Pharmaceuticals

China

Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infective APIs and finished dosage forms (FDFs). With over 120 years of pharmaceutical manufacturing heritage, they supply APIs and sterile injectables to over 500 pharmaceutical companies across 80 countries. Also operates as a CMO for third-party sterile injectable production.

Xi'an Wanlong Pharmaceutical

China

Xi'an Wanlong Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise founded in 1995, primarily producing formulations, APIs, and intermediates with GMP and DMF compliance. The Yangling facility spans 200,000 sq.m. with 18 production lines for injections, tablets, capsules, powder, and raw materials.

XL LABORATORIES PVT LTD

India

XL Laboratories Pvt Ltd is an EU GMP, PIC/s, TGA, and WHO GMP approved pharmaceutical formulations and nutraceuticals research and manufacturing company established in 2001. It holds Star Export House status from the Indian Ministry of Commerce for outstanding international market performance, with presence in 40+ countries.

YooYoung Pharmaceutical Co., Ltd.

South Korea

YooYoung Pharmaceutical Co., Ltd. is a South Korean pharmaceutical manufacturer founded in 1981. The company operates a KGMP-certified factory in Jincheon with capabilities for oral solid dosage (800 million tablets/year), ampoule injectables (25 million/year), and prefilled syringe injectables (15 million syringes/year after 2021 expansion). Offers CMO/contract manufacturing services and exports to Japan, Asia, Europe, and South America.

Yposkesi (an SK pharmteco company)

France

Yposkesi, an SK pharmteco company, is one of Europe's largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. Based near Paris (Evry-Courcouronnes), the company provides end-to-end gene therapy CDMO services including process development, cGMP manufacturing, analytical testing, and regulatory support for AAV, lentivirus, and other viral vectors.

Zhejiang Ausun Pharmaceutical Co Ltd

China

Zhejiang Ausun Pharmaceutical Co., Ltd., established in 2010 and listed on the Shanghai Stock Exchange (2017), is a Chinese pharmaceutical company based in the Taizhou Bay Economic Development Zone, Zhejiang Province. The company specializes in R&D, production, and sale of formulations (capsules, tablets) and active pharmaceutical ingredients. They are FDA-registered (FEI 3009065969) with 3 FDA inspections (1 NAI, 2 VAI, 0 OAI), have 2 FDA-approved products (capsule and tablet, oral route), hold US DMF filings, and have participated in 1 clinical trial (Infectious Disease). They employ 1,000-4,999 people. Their website was blocked (403 WAF), so details come primarily from search results and FDA regulatory data.

Adare Pharma Solutions

Italy

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services from product development through commercial manufacturing, focused on oral dosage forms. They specialize in taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. They have developed and manufactured more than 65 products sold in over 100 countries globally.

AdhexPharma

France

AdhexPharma is an independent French CDMO specializing in the development and manufacturing of transdermal patches, topical patches, and oral dissolving films. With over 40 years of experience, they produce 180 million units annually and have 15+ ongoing development projects. They are cGMP compliant with both EMA and FDA standards and recently acquired tesa Labtec GmbH to expand capabilities.